Increased incidence of unilateral sudden sensorineural hearing loss in patients with hematological malignancies requiring hematopoietic stem cell transplantation

xlomafota13 shared this article with you from Inoreader Increased incidence of unilateral sudden sensorineural hearing loss in patients with hematological malignancies requiring hematopoietic stem cell transplantation Via Clinical Otolaryngology Abstract Haematopoietic stem cell transplantation (HSCT) may dramatically alter the immunity of a recipient Transient immunodeficiency that occurs before and after HSCT could be associated with the development of sudden sensorineural hearing loss (SSNHL), which is presumed to be often due to viral aetiology We found an incidence of SSNHL of 29.4 per 10,000 person-years in patients receiving HSCT, 12-fold higher than reported for background population incidence Development of SSNHL tended to cluster early after diagnosis of haematological malignancies, rather than around date of treatment with HSCT Increased risk of unilateral SSNHL in patients with haematological malignancy may relate to underlying disease rather than treatment View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.